ConnectLife has an important role in providing organ and tissue samples for researchers locally, nationally, and internationally. This allows donor families the opportunity to participate in critical research to advance progress in understanding and treating human disease.
If you are interested in a research partnership with ConnectLife please complete this form and submit to Kayla Giancarlo email@example.com.
Notable Current and Former Research Partners:
NDRI (National Disease Research Interchange) http://ndriresource.org/
NDRI is the nation’s premier source of research tissue. By serving as the liaison between tissue and organ donors and the scientific community, NDRI is uniquely positioned to support breakthrough research in health care on disease states like HIV AIDS, cancer, diabetes, arthritis, heart disease, and many more.
ConnectLife is NDRI’s number 1 source for research tissue
Noted projects ConnectLife is involved in with NDRI-
Rare Disease Initiative
Diabetes, pancreatic islet research
Roswell Park Comprehensive Cancer Center https://www.roswellpark.org/
From its inception, Roswell Park Comprehensive Cancer Center identified cancer research as a core element of its mission. Since then, groundbreaking research by RPCCC scientists has led to greater understanding of the nature of cancer and to major advances in cancer diagnosis and treatment.
Noted projects ConnectLife is involved in with Roswell Park-
Rapid Tissue Acquisition Program (RTAP)
Prostate cancer research
Metastatic disease research
Genotype-Tissue Expression Project (GTEx) http://www.genome.gov/gtex/
The aim of the GTEx project is to increase understanding of how changes in our genes contribute to common human diseases, in order to improve health care for future generations.
Launched by the National Institutes of Health (NIH) in September 2010, GTEx will create a resource that researchers can use to study how inherited changes in genes lead to common diseases. It will establish a database and a tissue bank that can be used by many researchers around the world for future studies.
Organizations involved in this project are the National Cancer Institute, National Institute of Health, and the National Human Genome Research Institute.
ConnectLife was one of two biospecimen source sites for providing research tissues for the project.
SUNY Buffalo School of Medicine and Biomedical Sciences https://medicine.buffalo.edu/
SUNY Upstate Medical University http://www.upstate.edu/
Foundation Fighting Blindness http://www.blindness.org/
The mission of the Foundation Fighting Blindness is to drive research providing preventions, treatments and cures for people affected by blinding retinal diseases.
Noted projects ConnectLife is involved in with the Foundation Fighting Blindness-
Research providing prevention, treatment, and cure of retinitis pigmentosa, macular degeneration, and other retinal diseases.
Jacobs Neurologic Institute http://www.thejni.org/
The Harvard Brain Tissue Resource Center http://www.brainbank.mclean.org/
Autism BrainNet https://www.autismbrainnet.org
University of Miami Brain Endowment Bank http://brainbank.med.miami.edu/
The Brain Endowment Bank is a NeuroBioBank, which links tissue specimens to patient clinical data.
Noted projects ConnectLife is involved in with the Brain Endowment Bank-
Providing the scientific community with brain and tissues to investigate the progression of neurological and psychiatric diseases with the hope of developing pharmaceutical treatments and finding cures.
University of Minnesota http://twin-cities.umn.edu/
As the global leader in eye care, Alcon develops and manufactures innovative medicines and devices to serve the full life cycle of eye care needs.
IIAM - https://iiam.org/
IIAM provides non-transplantable, human organs and tissue authorized for medical research, education and development. IIAM works with organ procurement organizations, tissue banks and donor families in the U.S. to provide these biomaterials to qualified medical and scientific professionals around the world.
Promethera - https://www.promethera.com/
Promethera's mission is to bring patients life-saving treatments to reduce the need for liver transplantation.